NCT02710253View on ClinicalTrials.gov

Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

May 25, 2016

Primary Completion Date

May 30, 2026

Study Completion Date

May 30, 2026

Conditions
Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid Neoplasm
Interventions
RADIATION

External Beam Radiation Therapy

Undergo EBRT

OTHER

Laboratory Biomarker Analysis

Correlative studies

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

Trial Locations (5)

77030

RECRUITING

M D Anderson Cancer Center, Houston

77079

RECRUITING

MD Anderson West Houston, Houston

77384

RECRUITING

MD Anderson in The Woodlands, Conroe

77478

RECRUITING

MD Anderson in Sugar Land, Sugar Land

77573

RECRUITING

MD Anderson League City, League City

Sponsors

Collaborators (1)

Artidis
All Listed Sponsors
collaborator

Artidis

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER